Psychedelic Phylogenetics

Using molecular markers, researchers reconstruct the “magic” mushroom family tree.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, AFGOOEY74Species of Psilocybe fungi—known for the hallucinogenic effects of their active compound psilocybin, which is under study for their medicinal properties—have found homes within a new family tree thanks to researchers from the University of Guadalajara in Mexico. In a study published in Botany this week (August 6), the researchers reconstruct a multigene phylogeny for Psilocybe, the related, non-hallucinogenic genus Deconica, and other fungi exemplars using three nuclear markers. Altogether, the team sampled 28 specimens of Psilocybe, 14 of Deconica, and 24 outgroup taxa in its molecular analysis.

“Although taxon sampling included only 14.5 percent of the world total estimate of Psilocybe . . . we sampled species exhibiting all morphological variation in both genera,” Guadalajara’s Laura Guzmán-Dávalos and her colleagues wrote in the paper.

The phylogenetic analysis unearthed evidence suggesting that morphological traits shared among species of Psilocybe and Deconica were not because of a shared ancestor. Rather, the researchers said, those traits likely evolved independently in response to ecological pressures.

“The family placement of Psilocybe and Deconica has been the subject of much debate,” the researchers wrote. Guzmán-Dávalos and her colleagues noted Psilocybe is a polyphyletic group within the family Hymenogastraceae. However, they added that a formal classification will require an analysis of even more species, especially in Deconica.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies